European Union - English - EMA (European Medicines Agency)

theratechnologies europe limited - ibalizumab - hiv infections - antivirals for systemic use - trogarzo, in combination with other antiretroviral(s), is indicated for the treatment of adults infected with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive antiviral regimen.

European Union - English - EMA (European Medicines Agency)

alexion europe sas - eculizumab - hemoglobinuria, paroxysmal - immunosuppressants - soliris is indicated in adults and children for the treatment of:paroxysmal nocturnal haemoglobinuria (pnh).evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history (see section 5.1). atypical haemolytic uremic syndrome (ahus).soliris is indicated in adults for the treatment of:refractory generalized myasthenia gravis (gmg) in patients who are anti-acetylcholine receptor (achr) antibody-positive (see section 5.1).neuromyelitis optica spectrum disorder (nmosd) in patients who are anti-aquaporin-4 (aqp4) antibody-positive with a relapsing course of the disease.

Canada - English - Health Canada

novartis pharmaceuticals canada inc - omalizumab - powder for solution - 150mg - omalizumab 150mg - respiratory agents, miscellaneous

Canada - English - Health Canada

novartis pharmaceuticals canada inc - omalizumab - solution - 75mg - omalizumab 75mg - respiratory agents, miscellaneous

Canada - English - Health Canada

novartis pharmaceuticals canada inc - omalizumab - solution - 150mg - omalizumab 150mg - respiratory agents, miscellaneous

Canada - English - Health Canada

emd serono, a division of emd inc., canada - efalizumab - powder for solution - 150mg - efalizumab 150mg - misc. skin and mucous membrane agents

Canada - English - Health Canada

alexion pharma gmbh - eculizumab - solution - 10mg - eculizumab 10mg - complement inhibitors

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - omalizumab -

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - omalizumab - injection, powder, lyophilized, for solution - 150mg - omalizumab 150mg

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - omalizumab - injection, powder, lyophilized, for solution - 75mg - omalizumab 75mg